Literature DB >> 30467329

Epidemiology of cardiovascular disease in China: current features and implications.

Dong Zhao1, Jing Liu2, Miao Wang2, Xingguang Zhang2, Mengge Zhou2.   

Abstract

Cardiovascular disease (CVD) is the leading cause of death in China. To develop effective and timely strategies to cope with the challenges of CVD epidemics, we need to understand the current epidemiological features of the major types of CVD and the implications of these features for the prevention and treatment of CVD. In this Review, we summarize eight important features of the epidemiology of CVD in China. Some features indicate a transition in CVD epidemiology owing to interrelated changes in demography, environment, lifestyle, and health care, including the rising burden from atherosclerotic CVD (ischaemic heart disease and ischaemic stroke), declining mortality from haemorrhage stroke, varied regional epidemiological trends in the subtypes of CVD, increasing numbers of patients with moderate types of ischaemic heart disease and ischaemic stroke, and increasing ageing of patients with CVD. Other features highlight the problems that need particular attention, including the high proportion of out-of-hospital death of patients with ischaemic heart disease with insufficient prehospital care; the wide gaps between guideline-recommended goals and levels of lifestyle indicators; and the huge number of patients with undiagnosed, untreated, or uncontrolled hypertension, hypercholesterolaemia, or diabetes mellitus.

Entities:  

Mesh:

Year:  2019        PMID: 30467329     DOI: 10.1038/s41569-018-0119-4

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN: 1759-5002            Impact factor:   32.419


  209 in total

1.  Network Pharmacology-Based Exploration of Synergistic Mechanism of Guanxin II Formula (II) for Coronary Heart Disease.

Authors:  Song Sheng; Zhi-Xu Yang; Feng-Qin Xu; Ye Huang
Journal:  Chin J Integr Med       Date:  2020-05-09       Impact factor: 1.978

2.  Benefits and Risks Associated with Low-Dose Aspirin Use for the Primary Prevention of Cardiovascular Disease: A Systematic Review and Meta-Analysis of Randomized Control Trials and Trial Sequential Analysis.

Authors:  Mingming Wang; Haijie Yu; Zuojing Li; Daxin Gong; Xiaoxi Liu
Journal:  Am J Cardiovasc Drugs       Date:  2022-05-16       Impact factor: 3.571

Review 3.  Exosomes in Myocardial Infarction: Therapeutic Potential and Clinical Application.

Authors:  Wenjian Nian; Cong Fu
Journal:  J Cardiovasc Transl Res       Date:  2022-06-07       Impact factor: 4.132

4.  Doxorubicin and subsequent risk of cardiovascular diseases among survivors of diffuse large B-cell lymphoma in Hong Kong.

Authors:  Shing Fung Lee; Miguel Angel Luque-Fernandez; Yu Hui Chen; Paul J Catalano; Chi Leung Chiang; Eric Yuk-Fai Wan; Ian Chi-Kei Wong; Ming Hui Chen; Andrea K Ng
Journal:  Blood Adv       Date:  2020-10-27

Review 5.  Biodiversity-based development and evolution: the emerging research systems in model and non-model organisms.

Authors:  Long Zhao; Feng Gao; Shan Gao; Yujun Liang; Hongan Long; Zhiyi Lv; Ying Su; Naihao Ye; Liusuo Zhang; Chengtian Zhao; Xiaoyu Wang; Weibo Song; Shicui Zhang; Bo Dong
Journal:  Sci China Life Sci       Date:  2021-04-22       Impact factor: 6.038

6.  Peripheral white blood cell counts mediated the associations of sleep duration with atherosclerotic cardiovascular disease risk: a cross-sectional study of middle-aged and older Chinese.

Authors:  Xiaobing Feng; Dongming Wang; Ruyi Liang; Man Cheng; Limin Cao; Yang Xiao; Min Zhou; Meian He; Xiaomin Zhang; Jing Yuan; Weihong Chen
Journal:  Sleep Breath       Date:  2021-03-18       Impact factor: 2.816

7.  Association of Lipoprotein (a) variants with risk of cardiovascular disease: a Mendelian randomization study.

Authors:  Juan Xia; Chunyue Guo; Kuo Liu; Yunyi Xie; Han Cao; Wenjuan Peng; Yanyan Sun; Xiaohui Liu; Bingxiao Li; Ling Zhang
Journal:  Lipids Health Dis       Date:  2021-06-01       Impact factor: 3.876

8.  Highly Efficient MicroRNA Delivery Using Functionalized Carbon Dots for Enhanced Conversion of Fibroblasts to Cardiomyocytes.

Authors:  Lei Yang; Song Xue; Mingjun Du; Feng Lian
Journal:  Int J Nanomedicine       Date:  2021-06-01

9.  miR-22 eluting cardiovascular stent based on a self-healable spongy coating inhibits in-stent restenosis.

Authors:  Jing Wang; Hong-Lin Qian; Sheng-Yu Chen; Wei-Pin Huang; Dan-Ni Huang; Hong-Ye Hao; Ke-Feng Ren; Yun-Bing Wang; Guo-Sheng Fu; Jian Ji
Journal:  Bioact Mater       Date:  2021-05-20

10.  Network Pharmacology-Based Systematic Analysis of Molecular Mechanisms of Dingji Fumai Decoction for Ventricular Arrhythmia.

Authors:  Yi Liang; Bo Liang; Xin-Rui Wu; Wen Chen; Li-Zhi Zhao
Journal:  Evid Based Complement Alternat Med       Date:  2021-05-08       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.